Sign in

You're signed outSign in or to get full access.

Sila Realty Trust (SILA)

--

Earnings summaries and quarterly performance for Sila Realty Trust.

Recent press releases and 8-K filings for SILA.

Sila Realty Trust Reports Q4 2025 Financial Results and Strategic Updates
SILA
Earnings
M&A
New Projects/Investments
  • Sila Realty Trust reported strong financial results for 2025, with Cash NOI increasing 0.8% to $169.9 million and FFO per share rising 3.6% to $2.16, though AFFO per share decreased 5.8% to $2.18.
  • The company executed on its growth strategy in 2025 by acquiring 6 healthcare facilities for approximately $150 million and further optimized its portfolio through planned dispositions in early 2026, including the sale of the Saginaw facility for $14.5 million.
  • Portfolio quality improved with the investment grade rated tenant percentage increasing 2.3% year-over-year to 40.6% and a weighted average remaining lease term of 10 years at year-end 2025.
  • Sila maintains a conservative balance sheet with net debt to EBITDAre at 3.9 times and over $480 million in total liquidity, providing substantial capacity to deploy $225 million to $375 million for acquisitions or investments in existing properties.
3 days ago
Sila Realty Trust Reports Q4 and Full-Year 2025 Financial Results and Strategic Updates
SILA
Earnings
M&A
New Projects/Investments
  • Sila Realty Trust reported full-year 2025 Cash NOI of $169.9 million, a 0.8% increase from 2024, and FFO per share of $2.16, a 3.6% increase year-over-year, while AFFO per share decreased by 5.8% to $2.18.
  • The company acquired 6 healthcare facilities for approximately $150 million in 2025 and closed on another $43.1 million facility after year-end. It also executed purchase and sale agreements for three properties toward year-end 2025, with one sale closing for $14.5 million after year-end.
  • Sila maintained a strong balance sheet with net debt to EBITDAre at 3.9 times at year-end 2025, below its target range, and total liquidity exceeding $480 million. The company has the capacity to deploy $225 million to reach the midpoint of its target leverage.
  • Portfolio quality improved, with investment grade rated tenant guarantor and affiliate percentage increasing to 40.6% and the weighted average remaining lease term extending to 10 years by year-end 2025. The portfolio-wide EBITDARM rent coverage ratio was 5.9x in 2025.
3 days ago
Sila Realty Trust Announces Q4 and Full Year 2025 Financial Results
SILA
Earnings
New Projects/Investments
Debt Issuance
  • Sila Realty Trust reported Q4 2025 total revenues of $50,700 thousand and net income attributable to common stockholders of $5,015 thousand, resulting in diluted EPS of $0.09. For the full year 2025, total revenues reached $197,536 thousand and diluted EPS was $0.60.
  • Key non-GAAP metrics for Q4 2025 included diluted FFO per common share of $0.54, diluted Core FFO per common share of $0.57, and diluted AFFO per common share of $0.55.
  • As of December 31, 2025, the company's portfolio comprised 140 properties with a leased rate of 98.7% and a weighted average remaining lease term of 10.0 years. Sila Realty Trust completed $148,877 thousand in acquisitions during 2025.
  • Financial health indicators as of December 31, 2025, included an interest coverage ratio of 4.3x, a net debt to EBITDAre ratio of 3.9x, and liquidity of $481,288 thousand.
3 days ago
Sila Realty Trust Reports Q4 2025 Earnings, Highlights Acquisitions and Strong Balance Sheet
SILA
Earnings
New Projects/Investments
M&A
  • Sila Realty Trust reported FY 2025 FFO per share of $2.16, a 3.6% increase year-over-year, and Cash NOI of $169.9 million, up 0.8% from FY 2024.
  • In 2025, the company acquired 6 healthcare facilities for approximately $150 million and completed over $7 million in redevelopment opportunities. After year-end, another facility was acquired for $43.1 million.
  • The balance sheet remains strong with net debt to EBITDAre at 3.9 times and over $480 million in total liquidity at year-end 2025, providing capacity to invest up to $375 million.
  • Tenant credit quality improved, with the investment grade rated tenant percentage increasing by 2.3% year-over-year to 40.6%, and the portfolio-wide EBITDARM rent coverage ratio rising to 5.9x in 2025.
  • The company executed purchase and sale agreements for three properties, closing one for $14.5 million after year-end, and anticipates further dispositions in Q1/Q2 2026.
3 days ago
Sila Realty Trust Announces Fourth Quarter and Year Ended 2025 Results
SILA
Earnings
Dividends
New Projects/Investments
  • Sila Realty Trust reported net income of $5.0 million and AFFO of $30.4 million for the fourth quarter of 2025, resulting in $0.09 per diluted share and $0.55 per diluted share, respectively. For the full year ended December 31, 2025, net income was $33.1 million and AFFO was $120.9 million, or $0.60 per diluted share and $2.18 per diluted share, respectively.
  • The company declared and paid cash distributions of $0.40 per share for the fourth quarter of 2025, totaling $1.60 per share for the full year. The Board authorized a quarterly cash dividend of $0.40 per share on February 23, 2026, payable on March 18, 2026. The AFFO payout ratio for Q4 2025 was 72.6%.
  • As of December 31, 2025, Sila's portfolio consisted of 140 properties comprising approximately 5.3 million rentable square feet, with a 98.7% leased rate and a 10.0-year weighted average remaining lease term. During 2025, the company acquired six operating healthcare properties for $148.9 million.
  • Sila ended 2025 with a strong liquidity position of approximately $481.3 million and a net debt to annualized EBITDAre ratio of 3.9x.
  • Subsequent to year-end, on January 15, 2026, Sila acquired one inpatient rehabilitation facility for $43.1 million, and on January 29, 2026, sold the Saginaw Healthcare Facility for $14.5 million.
4 days ago
SILA announces Q3 2025 financial results
SILA
Earnings
Debt Issuance
Revenue Acceleration
  • SILA reported rental revenue of $49,421 thousand and net income attributable to common stockholders of $11,609 thousand for Q3 2025.
  • For Q3 2025, diluted FFO per common share, Core FFO per common share, and AFFO per common share were all $0.56.
  • As of September 30, 2025, the company's net debt to EBITDAre ratio was 3.9x and its interest coverage ratio was 4.7x.
  • Total debt amounted to $676.0 million as of Q3 2025, with notable maturities including $250 million in 2025 and $275 million in 2026.
  • The largest tenant, PAM Health, accounts for 15.1% of revenue, and 39.5% of tenants/guarantors are investment grade rated.
Nov 5, 2025, 4:00 PM
Sila Realty Trust Reports Q3 2025 Financial Results and Strategic Investments
SILA
Earnings
New Projects/Investments
Share Buyback
  • Sila Realty Trust reported Q3 2025 cash NOI of $42.8 million, a 4.9% increase from Q3 2024, with 1.2% same-store cash NOI growth. AFFO per share decreased by 0.8% compared to Q3 2024 but increased 4.2% compared to Q2 2025.
  • During Q3 2025, the company completed approximately $87 million in acquisitions, including the $16.3 million Southlake portfolio and the $70.5 million Reunion Novus portfolio.
  • Sila is also deploying capital for property redevelopments and expansions, with approximately $5 million for a Pam Health facility, an anticipated $12.5 million for the Dover facility, and $16 million for the Overland Park facility, all expected to yield attractive returns.
  • The company's board authorized a share repurchase program of up to $75 million over three years, limited to $25 million annually, effective August 4, 2025, though no shares were purchased in Q3. An at-the-market (ATM) program was also established.
  • Sila maintains a strong financial position with over $476 million in total liquidity and a net debt-to-EBITDA ratio of 3.9 times. The company expects 2025 G&A to be at the low end or slightly below the previously communicated range of $22.5 million to $23.5 million.
Nov 5, 2025, 4:00 PM
Sila Realty Trust Announces Third Quarter 2025 Results
SILA
Earnings
Share Buyback
New Projects/Investments
  • Sila Realty Trust, Inc. reported net income of $11.6 million, or $0.21 per diluted share, and Adjusted Funds From Operations (AFFO) of $31.1 million, or $0.56 per diluted share, for the third quarter ended September 30, 2025.
  • Cash Net Operating Income (Cash NOI) for Q3 2025 was $42.8 million, an increase from $40.8 million in Q3 2024, driven by acquisitions and 1.2% same-store Cash NOI growth.
  • During the quarter ended September 30, 2025, the company acquired two medical outpatient buildings for $16.3 million and two inpatient rehabilitation facilities for $70.5 million, along with additional land for $2.7 million.
  • The Board authorized a share repurchase program of up to $75.0 million over three years, with a $25.0 million limit in any twelve-month period, effective August 4, 2025.
  • Sila declared and paid cash distributions of $0.40 per share for the quarter ended September 30, 2025, and authorized a quarterly cash dividend of $0.40 per share payable on December 4, 2025.
Nov 4, 2025, 9:30 PM